These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28732508)

  • 1. Lysophosphatidic acid plasma concentrations in healthy subjects: circadian rhythm and associations with demographic, anthropometric and biochemical parameters.
    Michalczyk A; Budkowska M; Dołęgowska B; Chlubek D; Safranow K
    Lipids Health Dis; 2017 Jul; 16(1):140. PubMed ID: 28732508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between plasma lysophospholipids concentrations, chronic kidney disease and the type of renal replacement therapy.
    Michalczyk A; Dołęgowska B; Heryć R; Chlubek D; Safranow K
    Lipids Health Dis; 2019 Apr; 18(1):85. PubMed ID: 30947711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity.
    Hosogaya S; Yatomi Y; Nakamura K; Ohkawa R; Okubo S; Yokota H; Ohta M; Yamazaki H; Koike T; Ozaki Y
    Ann Clin Biochem; 2008 Jul; 45(Pt 4):364-8. PubMed ID: 18583620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of plasma lysophosphatidic acid levels in ovarian cancer patients: A case-control study and updated meta-analysis.
    Cao L; Zhang Y; Fu Z; Dong L; Yang S; Meng W; Li Y; Zhang W; Zhang J; Zheng C; Zhu H; Fan L
    J Obstet Gynaecol Res; 2015 Dec; 41(12):1951-8. PubMed ID: 26472266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressing postcollection lysophosphatidic acid metabolism improves the precision of plasma LPA quantification.
    Kano K; Matsumoto H; Kono N; Kurano M; Yatomi Y; Aoki J
    J Lipid Res; 2021; 62():100029. PubMed ID: 33524376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidic Acid is a Biomarker for Peritoneal Carcinomatosis of Gastric Cancer and Correlates with Poor Prognosis.
    Zeng R; Li B; Huang J; Zhong M; Li L; Duan C; Zeng S; Huang J; Liu W; Lu J; Tang Y; Zhou L; Liu Y; Li J; He Z; Wang Q; Dai Y
    Genet Test Mol Biomarkers; 2017 Nov; 21(11):641-648. PubMed ID: 28910191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C.
    Watanabe N; Ikeda H; Nakamura K; Ohkawa R; Kume Y; Aoki J; Hama K; Okudaira S; Tanaka M; Tomiya T; Yanase M; Tejima K; Nishikawa T; Arai M; Arai H; Omata M; Fujiwara K; Yatomi Y
    J Clin Gastroenterol; 2007 Jul; 41(6):616-23. PubMed ID: 17577119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible involvement of minor lysophospholipids in the increase in plasma lysophosphatidic acid in acute coronary syndrome.
    Kurano M; Suzuki A; Inoue A; Tokuhara Y; Kano K; Matsumoto H; Igarashi K; Ohkawa R; Nakamura K; Dohi T; Miyauchi K; Daida H; Tsukamoto K; Ikeda H; Aoki J; Yatomi Y
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):463-70. PubMed ID: 25425621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of significant differences in the corrected activity of lysophospholipase D, producer of phospholipid mediator lysophosphatidic acid, in incubated serum from women with and without ovarian tumors.
    Tokumura A; Tominaga K; Yasuda K; Kanzaki H; Kogure K; Fukuzawa K
    Cancer; 2002 Jan; 94(1):141-51. PubMed ID: 11815970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acid composition of lysophosphatidic acid and lysophosphatidylinositol in plasma from patients with ovarian cancer and other gynecological diseases.
    Shen Z; Wu M; Elson P; Kennedy AW; Belinson J; Casey G; Xu Y
    Gynecol Oncol; 2001 Oct; 83(1):25-30. PubMed ID: 11585410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophospholipids are potential biomarkers of ovarian cancer.
    Sutphen R; Xu Y; Wilbanks GD; Fiorica J; Grendys EC; LaPolla JP; Arango H; Hoffman MS; Martino M; Wakeley K; Griffin D; Blanco RW; Cantor AB; Xiao YJ; Krischer JP
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1185-91. PubMed ID: 15247129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods for quantifying lysophosphatidic acid in body fluids: a review.
    Jesionowska A; Cecerska E; Dolegowska B
    Anal Biochem; 2014 May; 453():38-43. PubMed ID: 24613261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lysophosphatidic acid in ovarian cancer patients].
    Sedlákova I; Vávrová J; Tosner J; Hanousek L
    Ceska Gynekol; 2006 Jul; 71(4):312-7. PubMed ID: 16956044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lysophosphatidic acid and malignant neoplasms].
    Jesionowska A; Cecerska-Heryć E; Marczuk N; Safranow K; Dołęgowska B
    Postepy Biochem; 2015; 61(4):381-7. PubMed ID: 27048092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysophosphatidic acid: an ovarian cancer marker.
    Sedláková I; Vávrová J; Tosner J; Hanousek L
    Eur J Gynaecol Oncol; 2008; 29(5):511-4. PubMed ID: 19051824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of lysophosphatidic acid in cerebrospinal fluid and plasma of patients with schizophrenia.
    Gotoh L; Yamada M; Hattori K; Sasayama D; Noda T; Yoshida S; Kunugi H; Yamada M
    Psychiatry Res; 2019 Mar; 273():331-335. PubMed ID: 30682553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of plasma lysophosphatidic acid levels in the differential diagnosis of ovarian cancer.
    Zhang YJ; Cao LY; Fu ZZ; Wang YJ; Wang GX; Gu T
    J Cancer Res Ther; 2015; 11(2):375-80. PubMed ID: 26148603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical introduction of lysophosphatidic acid and autotaxin assays].
    Yatomi Y
    Rinsho Byori; 2010 Jun; 58(6):631-5. PubMed ID: 20662276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased circulating plasma lysophosphatidic acid in patients with acute coronary syndrome.
    Dohi T; Miyauchi K; Ohkawa R; Nakamura K; Kishimoto T; Miyazaki T; Nishino A; Nakajima N; Yaginuma K; Tamura H; Kojima T; Yokoyama K; Kurata T; Shimada K; Yatomi Y; Daida H
    Clin Chim Acta; 2012 Jan; 413(1-2):207-12. PubMed ID: 21983165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of lysophosphatidic acid in ovarian cancer versus controls: a meta-analysis.
    Li YY; Zhang WC; Zhang JL; Zheng CJ; Zhu H; Yu HM; Fan LM
    Lipids Health Dis; 2015 Jul; 14():72. PubMed ID: 26174150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.